Clinical Trial Update: Comparison of AMCOP Bioactivator and High-pull Headgear in Treating Skeletal Class II Hyperdivergent Pediatric Patients

View source ↗

Summary

A completed clinical trial compared AMCOP Bioactivator to High-pull Headgear in treating Skeletal Class II malocclusion in hyperdivergent pediatric patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skeletal Class Ii Malocclusion

Snippet

Sponsor: University of Pavia | Conditions: Skeletal Malocclusion | Status: COMPLETED